Allan D. Spigelman

机构：Cancer Institute of New South Wales, UNSW Sydney, Cancer Australia, Hunter Genetics · ORCID：0000-0002-7409-1684

发表论文 258 篇 · 总被引 7274 次 · h-index 44

代表论文

• Variation in the risk of colorectal cancer in families with Lynch syndrome: a retrospective cohort study (2021 · The Lancet Oncology · 被引 124)
• A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study (2021 · The Lancet Oncology · 被引 99)
• Common variants in breast cancer risk loci predispose to distinct tumor subtypes (2022 · Breast Cancer Research · 被引 33)
• A tumor focused approach to resolving the etiology of DNA mismatch repair deficient tumors classified as suspected Lynch syndrome (2023 · Journal of Translational Medicine · 被引 22)
• Can butyrate prevent colon cancer? The AusFAP study: A randomised, crossover clinical trial (2023 · Contemporary Clinical Trials Communications · 被引 13)
• Significant detection of new germline pathogenic variants in Australian Pancreatic Cancer Screening Program participants (2021 · Hereditary Cancer in Clinical Practice · 被引 8)